GB0706173D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0706173D0 GB0706173D0 GBGB0706173.2A GB0706173A GB0706173D0 GB 0706173 D0 GB0706173 D0 GB 0706173D0 GB 0706173 A GB0706173 A GB 0706173A GB 0706173 D0 GB0706173 D0 GB 0706173D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0706173.2A GB0706173D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
| PCT/EP2008/053600 WO2008119720A1 (fr) | 2007-03-29 | 2008-03-27 | Dérivés de 1-(1-cyclobutyl-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one qui ont une activité sur le récepteur m1 et leur utilisation en médecine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0706173.2A GB0706173D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0706173D0 true GB0706173D0 (en) | 2007-05-09 |
Family
ID=38050492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0706173.2A Ceased GB0706173D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0706173D0 (fr) |
| WO (1) | WO2008119720A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5209481B2 (ja) | 2005-09-30 | 2013-06-12 | グラクソ グループ リミテッド | M1受容体にて活性を有する化合物および医薬におけるそれらの使用 |
| JP5209479B2 (ja) | 2005-09-30 | 2013-06-12 | グラクソ グループ リミテッド | M1受容体にて活性を有するベンゾイミダゾロン類 |
| JP5209480B2 (ja) | 2005-09-30 | 2013-06-12 | グラクソ グループ リミテッド | M1受容体にて活性を有する化合物および医薬におけるそれらの使用 |
| GB0718415D0 (en) | 2007-09-20 | 2007-10-31 | Glaxo Group Ltd | Compounds |
| CN104177327B (zh) * | 2014-08-26 | 2016-03-23 | 上海应用技术学院 | 6-氨基-2-硫杂螺[3,3]庚烷盐酸盐的制备方法 |
| CN104292208A (zh) * | 2014-09-09 | 2015-01-21 | 上海师范大学 | 7-苯基-6,8-二氧杂螺[3.5]壬烷-2-羧酸及其制备方法 |
| CN106045916B (zh) * | 2016-05-31 | 2018-08-31 | 江苏之江化工有限公司 | 一种咪唑酮类化合物的合成方法 |
| CN111320535B (zh) * | 2020-03-09 | 2022-04-01 | 苏州楚凯药业有限公司 | 一种3-(苄氧基)-1-环丁酮的制备方法 |
| CN113443986A (zh) * | 2020-03-27 | 2021-09-28 | 南京药石科技股份有限公司 | 一种合成3-氧代-1-环丁烷羧酸的中间体的制备方法 |
| WO2023114224A1 (fr) | 2021-12-13 | 2023-06-22 | Sage Therapeutics, Inc. | Combinaison de modulateurs positifs du récepteur muscarinique et de modulateurs allostériques positifs de nmda |
| CN117003644B (zh) * | 2022-04-29 | 2025-07-04 | 帕潘纳(北京)科技有限公司 | 一种合成2-氯-6-硝基甲苯的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002515008A (ja) * | 1994-10-27 | 2002-05-21 | メルク エンド カンパニー インコーポレーテッド | ムスカリン・アンタゴニスト |
-
2007
- 2007-03-29 GB GBGB0706173.2A patent/GB0706173D0/en not_active Ceased
-
2008
- 2008-03-27 WO PCT/EP2008/053600 patent/WO2008119720A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008119720A8 (fr) | 2009-01-08 |
| WO2008119720A1 (fr) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0706793D0 (en) | Compounds | |
| GB0704407D0 (en) | Compounds | |
| GB0704394D0 (en) | Compounds | |
| GB0705672D0 (en) | Compounds | |
| GB0706173D0 (en) | Compounds | |
| GB0706168D0 (en) | Compounds | |
| GB0707092D0 (en) | Compounds | |
| GB0707034D0 (en) | Compounds | |
| GB0706188D0 (en) | Compounds | |
| GB0706165D0 (en) | Compounds | |
| GB0706174D0 (en) | Compounds | |
| GB0706189D0 (en) | Compounds | |
| GB0706187D0 (en) | Compounds | |
| GB0706167D0 (en) | Compounds | |
| GB0706190D0 (en) | Compounds | |
| GB0706170D0 (en) | Compounds | |
| GB0706164D0 (en) | Compounds | |
| GB0704939D0 (en) | Compounds | |
| GB0703756D0 (en) | Compounds | |
| GB0701985D0 (en) | Compounds | |
| GB0701955D0 (en) | Compounds | |
| GB0706023D0 (en) | Compounds | |
| GB0702960D0 (en) | Compounds | |
| GB0701981D0 (en) | Compounds | |
| GB0701977D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |